A PPAR-α-allopregnanolone (i.e., endocannabinoid-like/neurosteroids) cross-talk may have an impact for establishing relevant novel targets for the treatment of PTSD and major depression [9]. The gene discussed is PPARA; the disease is post-traumatic stress disorder.